Reverie Labs is a company developing machine learning drug discovery platform for cancer therapeutics. It was established in 2017 by Jonah Kallenbach, Ankit Gupta, and Connor Duffy. Reverie Labs has received funding investors such as Soma Capital, Wei Guo, and Uncommon Denominator. The company is headquartered in Boston, Massachusetts, United States.
Reverie Labs' technology is designed to be used in developing new therapeutics compound. It specifically aims to incorporate machine learning techniques to decrease the amount of time needed during the lead development phase. Some of the methodologies used include active learning to build client-specific databases and in silico testing on newly discovered molecules. Reverie Labs is focusing on discovering and developing their own cancer therapeutics, although it also offers its lead development technology for pharmaceutical companies' use.
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
March 16, 2018
Scaling Drug Development with Containerized Machine Learning
March 7, 2020
Training Transformers for Practical Drug Discovery with Tensor2Tensor
April 20, 2020